Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours
- PMID: 32320495
- DOI: 10.1111/his.14120
Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours
Abstract
Molecular biomarkers have come to constitute one of the cornerstones of oncological pathology. The method of classification not only directly affects the manner in which patients are diagnosed and treated, but also guides the development of drugs and of artificial intelligence tools. The aim of this article is to organise and update gastrointestinal molecular biomarkers in order to produce an easy-to-use guide for routine diagnostics. For this purpose, we have extracted and reorganised the molecular information on epithelial neoplasms included in the 2019 World Health Organization classification of tumours. Digestive system tumours, 5th edn.
Keywords: WHO; biomarkers; gastrointestinal neoplasms; genomics; molecular pathology.
© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd.
References
-
- Salto-Tellez M, Maxwell P, Hamilton P. Artificial intelligence-the third revolution in pathology. Histopathology 2019; 74; 372-376.
-
- Salto-Tellez M, Cree IA. Cancer taxonomy: pathology beyond pathology. Eur. J. Cancer 2019; 115; 57-60.
-
- Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin. Chem. 2007; 53; 1188-1190.
-
- Biomarkers in risk assessment: validity and validation. International Programme on Chemical Safety, IPCS I. Geneva: World Health Organization, 2001.
-
- Everett BM, Ridker PM. Biomarkers for cardiovascular screening: progress or passé? Clin. Chem. 2017; 63; 248-251.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
